News by Company
Drug made in Kalamazoo could be first to treat Parkinson’s | Woodtv.com
GRAND RAPIDS, Mich. (WOOD) — A diabetes drug developed in Kalamazoo is showing promise in treating Parkinson’s disease.
The Van Andel Research Institute says human trials will begin next year for MSDC-0160, which was created by Kalamazoo-based Metabolic Solutions Development Company to treat type 2 diabetes. If the trials are successful, it would become the world’s first therapy to treat the debilitating disease and slow its progression.